BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022.

Autor: Waters L; Central and North West London NHS Foundation Trust, Winston A; Imperial College London and Imperial College Healthcare NHS Trust, London, Reeves I; Homerton Hospital NHS Trust, London, Boffito M; Chelsea and Westminster Hospital NHS Foundation Trust, London, Churchill D; University Hospitals Sussex NHS Foundation Trust, Cromarty B; UK Community Advisory Board and Yorkshire Mesmac, Dunn D; University College London, Fink D; University College London, Fidler S; Imperial College London and Imperial College Healthcare NHS Trust, London, Foster C; Imperial College Healthcare NHS Trust, London, Fox J; Guys and St Thomas’ NHS Foundation Trust and Kings College London, Gupta R; University of Cambridge, Hilton A; UK Community Advisory Board and HiVitality, Khoo S; University of Liverpool, Leen C; NHS Lothian, Mackie N; Imperial College Healthcare NHS Trust, London, Naous N; Chelsea and Westminster Hospital NHS Foundation Trust, London, Ogbonmwan D; University Hospital North Durham, Durham, Orkin C; Queen Mary University of London, Panton L; Western General Hospital, Edinburgh, Post F; King's College Hospital NHS Foundation Trust, London, Pozniak A; Chelsea and Westminster Hospital NHS Foundation Trust, London, Sabin C; University College London, Walsh J; Imperial College Healthcare NHS Trust, London
Jazyk: angličtina
Zdroj: HIV medicine [HIV Med] 2022 Dec; Vol. 23 Suppl 5, pp. 3-115.
DOI: 10.1111/hiv.13446
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje